Neeraj Agarwal, Arun Azad, Joan Carles, Andre P. Fay, Nobuaki Matsubara, Cezary Szczylik, Ugo De Giorgi, Jae Young Joung, Peter C.C. Fong, Eric Voog, Robert Jones Jones, Neal D. Shore, Curtis J Dunshee, Stefanie Zschaebitz, Jan Oldenburg, Xun Lin, Cynthia Healy, Matko Kalac, Dana A. Kennedy, Karim Fizazi. "Final overall survival (OS) with talazoparib (TALA) + enzalutamide (ENZA) as first-line treatment in unselected patients with metastatic castration-resistant prostate cancer (mCRPC) in the phase 3 TALAPRO-2 trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.lba18